MediBIC Group provides healthcare and drug development services. It provides genetic testing services with diagnostic tools to doctors; GLP-compliant gene profiling services to pharmaceutical companies; and sample banking and management services, as well as focuses on providing health care services to pets. The company is also involved in developing a cell culture system; selling consumables; promoting licensing activities for the pancreatic cancer drug Glufosfamide; the research and development of pharmaceuticals and diagnostic agents, etc.; and providing data analysis for preventive health care, as well as clinical trial services to cell therapy. MediBIC Group was founded in 2000 and is headquartered in Tokyo, Japan.
medibic group (2369:Tokyo)
Rohto Tokyo Building
Phone: 81 3 5439 9691
Fax: 81 3 5439 9696www.medibic.com
The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content.
|No competitor information is available for 2369.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|
Sponsored Financial Commentaries
To contact MEDIBIC GROUP, please visit www.medibic.com. Company data is provided by Capital IQ. Please use this form to report any data issues.